Applied DNA Sciences, Inc. (APDN) financial statements (2022 and earlier)

Company profile

Business Address 50 HEALTH SCIENCES DRIVE
STONY BROOK, NY 11790
State of Incorp. DE
Fiscal Year End September 30
SIC 738 - Miscellaneous Business Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,748 7,7875591,660
Cash and cash equivalents2,748 7,7875591,660
Receivables3,857 1948401,486
Inventory, net of allowances, customer advances and progress billings1,301 497143221
Inventory1,301 497143221
Other undisclosed current assets593 599605635
Total current assets:8,499 9,0782,1464,002
Noncurrent Assets
Property, plant and equipment2,808 1,278226420
Intangible assets, net (including goodwill)  8911,0201,150
Goodwill  285285285
Intangible assets, net (excluding goodwill)  605735864
Deposits noncurrent assets95 956262
Deferred costs   110 
Total noncurrent assets:2,903 2,2631,4181,632
TOTAL ASSETS:11,402 11,3413,5655,634
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,521 1,9261,617965
Accounts payable1,761 1,2501,152501
Accrued liabilities364 15113163
Employee-related liabilities397 526319401
Taxes payable   15 
Deferred revenue458 511629
Debt  1,828  
Other undisclosed current liabilities    1,857
Total current liabilities:2,979 4,2662,2462,822
Noncurrent Liabilities
Long-term debt and lease obligation  5171,4421,587
Long-term debt, excluding current maturities  5171,4421,587
Liabilities, other than long-term debt31 848622471
Accounts payable and accrued liabilities31 848622471
Other undisclosed noncurrent liabilities   103 
Total noncurrent liabilities:31 1,3662,1672,057
Total liabilities:3,010 5,6324,4134,879
Stockholders' equity
Stockholders' equity attributable to parent8,392 5,718(841)755
Common stock7 5130
Additional paid in capital297,228 275,549255,963249,090
Accumulated deficit(288,844) (269,836)(256,806)(248,366)
Stockholders' equity attributable to noncontrolling interest0 (9)(7) 
Total stockholders' equity:8,392 5,710(848)755
TOTAL LIABILITIES AND EQUITY:11,402 11,3413,5655,634

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
Revenues4,257 1,9315,3893,903
Cost of revenue(3,057) (721)(878)(1,207)
Cost of goods and services sold   (878) 
Other undisclosed gross profit2,299    
Gross profit:9,488 1,2114,5112,697
Operating expenses(14,837) (13,746)(13,636)(14,343)
Other undisclosed operating loss(8,199)    
Operating loss:(13,548) (12,535)(9,124)(11,646)
Nonoperating expense
(Other Nonoperating expense)
(192) (378)(43)(37)
Interest and debt expense  (26)(1,260)(1)
Loss from continuing operations before equity method investments, income taxes:(13,740) (12,939)(10,428)(11,685)
Other undisclosed income (loss) from continuing operations before income taxes4 (90)1,811(8)
Loss from continuing operations before income taxes:(13,736) (13,029)(8,617)(11,693)
Income tax expense (benefit)  3,505(15)(3,505)
Other undisclosed income from continuing operations2,862    
Loss before gain (loss) on sale of properties:(10,874) (9,524)(8,632)(15,198)
Other undisclosed net loss(2,862) (3,505)  
Net loss:(13,736) (13,029)(8,632)(15,198)
Net income (loss) attributable to noncontrolling interest(8) 29 
Other undisclosed net income attributable to parent    3,505
Net loss attributable to parent:(13,744) (13,027)(8,623)(11,693)
Other undisclosed net loss available to common stockholders, basic  (3)(310) 
Net loss available to common stockholders, diluted:(13,744) (13,030)(8,933)(11,693)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
9/30/2018
Net loss:(13,736) (13,029)(8,632)(15,198)
Comprehensive loss:(13,736) (13,029)(8,632)(15,198)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(8) 29 
Comprehensive loss, net of tax, attributable to parent:(13,744) (13,027)(8,623)(15,198)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: